• When and how to reverse Direct oral anticoagulants

    17 October 2018 01:30 - 02:30pm - Australia/Sydney 

    Direct oral anticoagulants (DOACs) are indicated for the prevention of systemic embolism in selected patients with non-valvular atrial fibrillation and for the prevention and /or treatment of venous thromboembolism. Guidance on when and how to reverse DOACs is discussed.

    Dr Simon McRae, Chairman, Australian Haemophilia Centre Directors Organisation, Consultant Haematologist SA Pathology, Royal Adelaide Hospital.

    Learning outcomes:

    • Describe the actions that should be taken when a patient presents with bleeding associated with the new oral anticoagulants

    • Understand perioperative management and other considerations

  • Feedback form and certificate

    If you attended this webinar, please complete the short feedback form to access your certificate.

    Otherwise, click the box above once you have watched the presentation to mark it as complete. To be eligible for your certificate, you must watch over half the presentation and complete the feedback form to download your certificate.